Ascendis Pharma trades higher; comments from Betaville cited for the move ($220.50, +10.34)
FDA extends PDUFA target action date for TransCon CNP by three months to 28-Feb-26 ($206.65, 0.00)
StreetAccount Summary: Notable Drug Events expected for the week of 23-Nov
Powered by FactSet Research Systems Inc.